CIBC Private Wealth Group LLC Buys 4,137 Shares of Corteva, Inc. (NYSE:CTVA)

CIBC Private Wealth Group LLC increased its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 18.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 26,073 shares of the company's stock after purchasing an additional 4,137 shares during the period. CIBC Private Wealth Group LLC's holdings in Corteva were worth $1,490,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the company. Public Sector Pension Investment Board boosted its position in shares of Corteva by 11.3% in the 3rd quarter. Public Sector Pension Investment Board now owns 29,502 shares of the company's stock worth $1,734,000 after purchasing an additional 3,000 shares in the last quarter. Benjamin Edwards Inc. boosted its holdings in Corteva by 64.9% in the third quarter. Benjamin Edwards Inc. now owns 8,528 shares of the company's stock worth $502,000 after acquiring an additional 3,357 shares in the last quarter. Holocene Advisors LP purchased a new stake in shares of Corteva in the third quarter worth $4,919,000. Hilltop Holdings Inc. increased its holdings in shares of Corteva by 27.5% during the third quarter. Hilltop Holdings Inc. now owns 9,852 shares of the company's stock valued at $579,000 after acquiring an additional 2,126 shares in the last quarter. Finally, Investment Management Corp of Ontario raised its position in shares of Corteva by 47.9% in the 3rd quarter. Investment Management Corp of Ontario now owns 23,143 shares of the company's stock worth $1,361,000 after purchasing an additional 7,500 shares during the last quarter. Institutional investors own 81.54% of the company's stock.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 26,560 shares of the company's stock in a transaction dated Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the transaction, the insider now owns 11,347 shares of the company's stock, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.14% of the company's stock.

Corteva Stock Performance

Shares of NYSE:CTVA traded up $0.15 during midday trading on Tuesday, hitting $55.72. The company had a trading volume of 785,512 shares, compared to its average volume of 3,251,153. The company has a market cap of $38.06 billion, a price-to-earnings ratio of 43.00, a PEG ratio of 1.68 and a beta of 0.73. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.45 and a quick ratio of 0.93. The company has a fifty day moving average of $62.18 and a two-hundred day moving average of $60.28. Corteva, Inc. has a 12-month low of $50.01 and a 12-month high of $66.24.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. On average, equities research analysts expect that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were given a $0.17 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.22%. Corteva's payout ratio is currently 52.71%.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on CTVA shares. Royal Bank of Canada lifted their target price on shares of Corteva from $72.00 to $73.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. Bank of America boosted their price objective on shares of Corteva from $69.00 to $73.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. UBS Group cut their target price on Corteva from $74.00 to $73.00 and set a "buy" rating on the stock in a research note on Friday, January 10th. Wells Fargo & Company boosted their price target on Corteva from $67.00 to $73.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 28th. Finally, Barclays increased their price objective on Corteva from $62.00 to $64.00 and gave the company an "equal weight" rating in a research report on Tuesday, January 21st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, Corteva has a consensus rating of "Moderate Buy" and an average price target of $68.06.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.